REVEALING NEW POSSIBILITIES IN RESEARCH

Diabetes and Endocrinology

Advance endocrinology drug and device development with our specialized focus on the right sites and the right treatments for patients.

Access deep and broad enterprise-wide expertise in endocrinology indications supported by therapeutic area experts in medical, regulatory, strategy and operations.

Expect unique insights from unparalleled endocrinology data to support protocol and clinical plan design and deliver better outcomes.

Supporting comprehensive endocrinology clinical trials.

Whether you need support with early phase adaptive trial design, site selection, patient identification or targeted services for late-phase endocrinology trials, trust the expertise of an agile and experienced partner to help advance your endocrinology drug, cell/gene therapy or device to market.

Our dedicated, global endocrinology team at Fortrea includes industry leaders in medical, operational, and strategy fields. We’re here to serve as a committed partner with the expertise and experience to deliver a comprehensive trial solution that fits your organization’s business and strategy.

Experience matters when choosing a partner.

Let's Connect

We’ve been honored to serve as a CRO partner of choice for our biotech and pharmaceutical customers as we’ve advanced their diabetes and endocrinology programs. In the last 5 years, we have supported:

460+

Studies

10,710+

Sites

131,680+

Patients

Top Indications

Providing expert support for your diabetes, obesity/metabolism and endocrinology trial.

As your partner, we offer our recent, ongoing and relevant experience in large portfolio of endocrinology trials from early phase to registrational, including novel cell and gene therapies. This includes our:

  • Extensive ongoing site relationships along with our Xcellerate® trial data with extensive central laboratory data* to enhance site selection and maximize patient recruitment. (*Fortrea will maintain exclusive CRO access to the Labcorp data that supports its clinical-enabling solutions for a fixed period of time.)
  • Strong connections to advocacy groups, investigators and organizations, such as JDRF, to promote patient access and increase community awareness. 
  • Robust experience in rare disorders appearing in childhood and adolescence along with unique capabilities in pituitary, adrenal and parathyroid hormone disorders.

Get to know us

An exceptional partnership starts with an experienced team. Browse the bios of our featured team members.

Rosemary Molinari Executive Director
Plamen Penev, MD, PhD Executive Medical Director
JB Flinders, PhD, MBA Senior Director, Operational Strategy and Planning
Meet the team

Advancing your precision medicine.

We bring extensive depth of expertise to endocrinology drug and device development. Our MDs and subject matter experts have helped bring many of today's precision medicines to market, from targeted therapies to immunotherapies to advanced cell and gene therapies. Our expertise enhances study designs and deliver operational efficiencies across the full range of development phases, and we provide novel solutions focused on CFR-compliant data aggregation—spanning CGM devices, SMBG and pediatric considerations in trials across issues of PK, blood volume and consent/assent.

Delivering agility at scale. 

Working with our dedicated, global endocrinology team, you can leverage our rich site performance database, operational experience with complex trial designs and established site relationships to reach your development goals faster. Throughout your development, we’ll apply our tools and medical, scientific and regulatory expertise to navigate complexities and eliminate inefficiencies. Together, let’s enable innovative, technology-driven solutions with a patient-centric approach as we deliver efficient clinical development plans and protocols in diabetes, obesity/metabolism and endocrinology. 

Stay up to date:
Subscribe for Fortrea news & announcements.

Subscribe Now